Astrid Eliasen

ORCID: 0000-0002-2261-0323
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nausea and vomiting management
  • Childhood Cancer Survivors' Quality of Life
  • Pediatric Pain Management Techniques
  • Pharmacological Effects and Toxicity Studies
  • Suicide and Self-Harm Studies
  • Thermal Regulation in Medicine
  • Pathogenesis and Treatment of Hiccups
  • Cancer-related cognitive impairment studies
  • Cancer Risks and Factors
  • Cardiac electrophysiology and arrhythmias
  • Receptor Mechanisms and Signaling
  • Growth Hormone and Insulin-like Growth Factors
  • Diabetes Treatment and Management
  • Gastroesophageal reflux and treatments
  • Traumatic Brain Injury Research
  • Acute Myocardial Infarction Research
  • Metabolism and Genetic Disorders
  • Pharmaceutical studies and practices
  • Ethics and Legal Issues in Pediatric Healthcare
  • Lipoproteins and Cardiovascular Health
  • Cancer therapeutics and mechanisms
  • Psychosomatic Disorders and Their Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Anesthesia and Sedative Agents
  • Atrial Fibrillation Management and Outcomes

Novo Nordisk (Denmark)
2024

Rigshospitalet
2019-2023

Frederiksberg Hospital
2018-2023

Copenhagen University Hospital
2018-2023

University of Copenhagen
2018-2022

Brigham and Women's Hospital
2008

Nausea and vomiting are common distressing side effects for children receiving chemotherapy. Limited evidence is available to guide antiemetic recommendations; therefore, prospective reliable evaluation of efficacy needed. Smartphone apps can be used effortlessly precisely collect patient-reported outcomes in real time.Our objective was develop a smartphone app monitor nausea episodes pediatric cancer patients aged 0 18 years test its usability adherence use.We user-centered design process...

10.2196/18564 article EN cc-by JMIR mhealth and uhealth 2020-05-13

Despite treatment with antiemetic medications, nausea remains uncontrolled for many children receiving chemotherapy. One reason is that risk factors in remain poorly explored. The purpose of this study was to identify chemotherapy-induced (CIN) children.Prospective, observational including 101 (median age 6.4 years, range 0.8-17.9) cancer moderately or highly emetogenic Primary endpoints were complete control acute and delayed CIN, defined as no the phase 0-24 h after chemotherapy starting...

10.1177/10781552221122026 article EN Journal of Oncology Pharmacy Practice 2022-08-29

The combination of cagrilintide and semaglutide (CagriSema) is being developed for the treatment obesity type 2 diabetes. objective this thorough QT study was to confirm that does not result in a clinically relevant prolongation cardiac repolarization compared with placebo.

10.1111/dom.15951 article EN cc-by-nc Diabetes Obesity and Metabolism 2024-09-16

Paracetamol is recommended as a first-line treatment for pain and fever in paediatric patients. Intravenous (IV) infusions are to be administered 15-min infusion minimize local tissue trauma related pain. The purpose of this study was demonstrate that IV paracetamol could during 5 ​min or less patients without causing adverse reactions.

10.1016/j.crphar.2021.100077 article EN cc-by Current Research in Pharmacology and Drug Discovery 2021-12-18

Chemotherapy-induced nausea and vomiting (CINV) remains a common adverse effect for children with cancer. In children, chemotherapy emetogenicity patient factors such as susceptibility to motion sickness age group determine patient’s risk of CINV. Besides known factors, genetic may play role in interindividual variation the occurrence We investigated influence candidate gene polymorphisms on efficacy antiemetics background sensitivity CINV children. This prospective study included 100 cancer...

10.1097/fpc.0000000000000460 article EN Pharmacogenetics and Genomics 2021-11-08

Introduction: Neurological diseases have a profound impact on quality of life. We investigated the risk suicide attempt in ten neurological diseases.

10.1254/jpssuppl.wcp2018.0_po2-1-21 article EN Proceedings for Annual Meeting of The Japanese Pharmacological Society 2018-01-01

<sec> <title>BACKGROUND</title> Nausea and vomiting are common distressing side effects for children receiving chemotherapy. Limited evidence is available to guide antiemetic recommendations; therefore, prospective reliable evaluation of efficacy needed. Smartphone apps can be used effortlessly precisely collect patient-reported outcomes in real time. </sec> <title>OBJECTIVE</title> Our objective was develop a smartphone app monitor nausea episodes pediatric cancer patients aged 0 18 years...

10.2196/preprints.18564 preprint EN 2020-03-05

Background Nausea is a common and distressing side effect for children in chemotherapy. Antiemetic recommendations are based on limited literature prospective evaluation of antiemetic efficacy required. Smartphone applications (apps) may collect patient-reported outcomes with precision effectiveness 1 . We developed smartphone app to track nausea pediatric cancer patients during Methods Medical researchers, oncologists software engineers worked synergistically the development. translated...

10.1136/archdischild-2019-esdppp.67 article EN Archives of Disease in Childhood 2019-05-17

Eliasen, Astrid; Schmiegelow, Kjeld; Rechnitzer, Catherine; Brok, Jesper; Dalhoff, Kim; Mathiasen, René Author Information

10.1097/fad.0000000000000055 article EN Adverse Drug Reaction Bulletin 2021-06-01
Coming Soon ...